Literature DB >> 11172300

Cyclin E immunoexpression in breast ductal carcinoma: pathologic correlations and prognostic implications.

R Donnellan1, I Kleinschmidt, R Chetty.   

Abstract

Abnormalities of the cell cycle are present in all neoplasms. Cyclin E, which regulates the G1/S phase transition of the cell cycle, plays an important role in many different cancers. To further investigate the role of cyclin E in invasive breast ductal carcinomas in South African women, representative sections from 157 mastectomy and axillary clearance specimens were stained with the cyclin E antibody. The results were compared with known clinicopathologic prognostic factors, namely lymph node metastases, size, estrogen receptor status, and histologic grade. Positive (nuclear) cyclin E immunostaining strongly correlates with negative estrogen receptor status and high grade. These correlations may account for the observation that although cyclin E staining is associated with poor prognosis in univariate analysis, no prognostic significance remains after multivariate analysis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11172300     DOI: 10.1053/hupa.2001.21141

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  14 in total

1.  Expression of cyclin D1 and cyclin E in urothelial bladder carcinoma detected in tissue chips using a quantum dot immunofluorescence technique.

Authors:  Guang Shan; Tian Tang
Journal:  Oncol Lett       Date:  2015-06-30       Impact factor: 2.967

2.  A study to investigate the role of p27 and cyclin E immunoexpression as a prognostic factor in early breast carcinoma.

Authors:  Komala Pillay; Heather McCleod; Runjan Chetty; Pauline Hall
Journal:  World J Surg Oncol       Date:  2011-03-16       Impact factor: 2.754

3.  Classical and Novel Prognostic Markers for Breast Cancer and their Clinical Significance.

Authors:  Pankaj Taneja; Dejan Maglic; Fumitake Kai; Sinan Zhu; Robert D Kendig; Elizabeth A Fry; Kazushi Inoue
Journal:  Clin Med Insights Oncol       Date:  2010-04-20

4.  Prognostic value of cyclin E expression in breast cancer: a meta-analysis.

Authors:  Sheng Gao; Jing-Jing Ma; Cheng Lu
Journal:  Tumour Biol       Date:  2013-06-18

5.  Cytoplasmic Cyclin E and Phospho-Cyclin-Dependent Kinase 2 Are Biomarkers of Aggressive Breast Cancer.

Authors:  Cansu Karakas; Anna Biernacka; Tuyen Bui; Aysegul A Sahin; Min Yi; Said Akli; Jolie Schafer; Angela Alexander; Opoku Adjapong; Kelly K Hunt; Khandan Keyomarsi
Journal:  Am J Pathol       Date:  2016-05-13       Impact factor: 4.307

6.  Cyclin E deregulation is an early event in the development of breast cancer.

Authors:  Alexandra Shaye; Aysegul Sahin; Qiang Hao; Kelly Hunt; Khandan Keyomarsi; Isabelle Bedrosian
Journal:  Breast Cancer Res Treat       Date:  2008-12-24       Impact factor: 4.872

7.  Cyclin D1 and cyclin E2 are differentially expressed in gastric cancer.

Authors:  Soni Kumari; Shyam Babu Prasad; Suresh Singh Yadav; Mohan Kumar; A Khanna; V K Dixit; Gopal Nath; Sunita Singh; Gopeshwar Narayan
Journal:  Med Oncol       Date:  2016-03-31       Impact factor: 3.064

8.  Cyclin E amplification, over-expression, and relapse-free survival in HER-2-positive primary breast cancer.

Authors:  Satu Luhtala; Synnöve Staff; Minna Tanner; Jorma Isola
Journal:  Tumour Biol       Date:  2016-01-26

9.  Identification of a three-gene expression signature of poor-prognosis breast carcinoma.

Authors:  Ivan Bièche; Sengül Tozlu; Igor Girault; Rosette Lidereau
Journal:  Mol Cancer       Date:  2004-12-20       Impact factor: 27.401

10.  Deregulation of cyclin E in human cells interferes with prereplication complex assembly.

Authors:  Susanna Ekholm-Reed; Juan Méndez; Donato Tedesco; Anders Zetterberg; Bruce Stillman; Steven I Reed
Journal:  J Cell Biol       Date:  2004-06-14       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.